Cancer detector Bard1 Life Sciences took investors on a rollercoaster ride Wednesday after adding breast cancer testing to its line-up earlier in the week. After tripling on Tuesday, the stock (ASX:BD1) put on another 70 per cent Wednesday morning to hit an intraday high of 7.5c. That’s a gain of about 475 per cent compared … Continue reading Cancer fighter Bard1 jumps more than 450pc before falling back to earth